Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Your research
Source: nct - Country: France,Spain,Taiwan, Province of China,Estonia,Australia,Israel,Korea, Republic of,Germany,Switzerland - Phase: complete
nct
Update Il y a 5 ans
Optimal Timing of Dronedarone Initiation After Conversion in Patients With Persistent Atrial Fibrillation
Primary Objective: - Evaluate the rate of Atrial Fibrillation (AF) recurrences one month after randomization according to different timings of initiation of dronedarone. Secondary Objective: - Evaluate the rate of AF recurrences two months after randomization. - Assess the safety of the change from amiodarone to dronedarone - Assess dronedarone safety - Explore dronedarone and its active metabolite plasma level (in a subset of countries) - Explore potential Pharmacokinetic (PK) interaction between dronedarone and amiodarone (in a subset of countries)
Country
Australia
,
Austria
,
Estonia
,
Finland
,
France
,
Germany
,
Israel
,
Italy
,
Korea, Republic of
,
Mexico
,
Netherlands
,
Portugal
,
Spain
,
Switzerland
,
Taiwan, Province of China
,
United Kingdom
,
organs
None
Specialty
None
Closed trial
More information
1